期刊档案
Visualized Cancer Medicine
ISSN 2740-4218 · EDP Sciences · France
Visualized Cancer Medicine 钻石开放获取(无 APC),免版面费,投稿社区反馈审稿约 8 周,2025 年发文 15 篇。
研究范围
研究范围与定位
Visualized Cancer Medicine 由 EDP Sciences 出版。按 OpenAlex 近年发文统计,该刊主要发表 Advanced Radiotherapy Techniques、Radiation Therapy and Dosimetry、Head and Neck Cancer Studies 等主题的论文,这 3 个主题约占 26%。(根据 OpenAlex 主题统计与中科院分区数据生成)
Visualized Cancer Medicine is an interdisciplinary and peer-reviewed journal, which publishes the advances in basic, translational, and clinical studies on cancer biology, cancer prevention, cancer screening and diagnosis, cancer treatments, and cancer patient rehabilitation, with an emphasis on videos presenting the natural process, interventional procedure, and spatial alteration of the studied objects. The journal’s aim is to provide a forum for original research papers, reviews, clinical case studies, technological advancements, historical reflections, and commentaries on relevant topics for better promotion of cancer prevention, early diagnosis, and more effective cancer treatments. The scope of Visualized Cancer Medicine includes, but is not limited to: Novel findings in molecular mechanisms of cancer biology. Scientific bases of the relationship between tumor microenvironments and treatment responses. Drug delivery impacted by tumor microenvironments and other factors. New approaches in investigating the onset of cancer, its promotion, and progression. Cancer prevention, screening and early detection. New diagnostic approaches. Clinical studies on cancer treatment targeting tumor microenvironments. Advances in cancer surgery. Novel radiotherapy approaches, including proton and heavy ion radiotherapies. Artificial intelligence in identifying cancer etiology, clinical diagnosis, and treatment planning. Visualized Cancer Medicine is the official journal of the Society of Tumor Microenvironment, China Anti-Cancer Association.
摘自期刊官网 Aims & Scope
主编 Chao-Nan Qian出版商官网
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Advanced Radiotherapy TechniquesPhysics and Astronomy11.7%
- Radiation Therapy and DosimetryMedicine7.8%
- Head and Neck Cancer StudiesMedicine6.5%
- Cancer Cells and MetastasisMedicine6.5%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine5.2%
- Lung Cancer Diagnosis and TreatmentMedicine5.2%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.2%
- Cancer Immunotherapy and BiomarkersMedicine3.9%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- h-index
- 7OpenAlex ·
- i10-index
- 6OpenAlex ·
- 两年平均被引
- 1.66OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 56 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 7 | 7 | 60 |
| 2025 | 15 | 15 | 53 |
| 2024 | 13 | 13 | 30 |
| 2023 | 9 | 9 | 24 |
| 2022 | 5 | 5 | 11 |
| 2021 | 6 | 6 | 5 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度(社区反馈)
- 8 WeeksLetPub ·
- 投稿到发表(期刊自报)
- 约 8 周DOAJ ·
- 评审方式
- 单盲同行评审、同行评审(未说明方式)DOAJ
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 有 | CC BY | |
| OpenAlex | EUR 0 | — | — | |
| LetPub | 无文章处理费 | 有 | — | |
| 出版商官网 | 有,金额未公布 | — | — |
其他费用与减免(作者指南)
- 费用减免
- 无费用减免
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点3 项,摘自作者指南
- 摘要
- ≤ 400 词
- 关键词
- 4–6 个
- 参考文献格式
- Vancouver 格式
接收的文章类型13 种,含篇幅限制
- clinical case studyEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- commentaries and historical reflectionsEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- commentaryEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- editorialEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- editorial forewordEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- just moviesEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- laboratory bases methodsEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- original research articleEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…正文 ≤ 6,000 词
- perspectiveEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…正文 ≤ 3,000 词
- perspective articleEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- review articleEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- surgical techniquesEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
- technological and methodological advancesEleven types of publications are considered: Original research article Review article Perspective article Technological and Methodological Advances Clinical cas…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、开放获取、同行评审、查重、试验注册 / 报告规范
- AI 使用 1.7 The Use of Artificial Intelligence (AI)-Assisted Technology
Concerning the use of AI in writing the research content, EDP Sciences adheres to the position of COPE. AI tools cannot be listed as author of a paper. AI tools cannot meet the requirements for authorship and cannot take responsibility for the submitted work, assert conflicts of interest, or manage copyright and license agreements. Authors must be transparent in disclosing how AI tools were used i…
原文 ↗出版商官网 ·- 作者资格 1.2 Authorship
ICMJE建议所有被指定为作者的人均须满足其描述的全部作者标准,标准清单见ICMJE网站;未满足全部标准的贡献者应列入致谢。 模型中文摘要
The ICMJE recommends that all those designated as authors meet all of the criteria they describe. The list of criteria is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/. Those contributors who do not meet all of the criteria shall be acknowledged.
原文 ↗出版商官网 ·- 利益冲突 1.3 Conflict of interest
作者必须披露与研究资助机构是否存在财务关系,并声明对全部原始数据拥有完全控制权、同意期刊在要求时审阅其数据;因此初次投稿时稿件必须附'利益冲突披露表',任何其他个人或其他层面的利益冲突也必须披露。 模型中文摘要
Authors must disclose whether or not they have a financial relationship with the organization that sponsored the research. They should also state that they have full control of all primary data and that they agree to allow the journal to review their data if requested. Therefore the manuscript must be accompanied by the "Conflicts of Interest Disclosure Form" at the initial submission. Any additio…
原文 ↗出版商官网 ·- 数据可用性 1.10 Data sharing policy
Authors strongly suggested to upload raw data onto Research Data Deposit (RDD) for verification. 模型摘要
Authors may be invited to share with the peer reviewers during the article evaluation process in a confidential manner the data on which the research is based. Further, as long as the publication of data is not in opposition with patients’ privacy, authors are invited to upload supplemental datasets related to their research to an online repository. Doing so makes it available for both human and m…
原文 ↗出版商官网 ·- 出版伦理 4.5.9 Ethical approval
该必填字段不得留空。若研究需要伦理批准,应写明所遵循的伦理规程及批准委员会名称,例如'本研究获得X医院伦理委员会批准,批准号XXXX';若不需要伦理批准,应声明'本研究无需伦理批准'。 模型中文摘要
This mandatory field should not be left empty. If your study requires ethical approval, please include the ethical protocols followed and the name of the committee, which approved the study. For example : “This study received ethical approval from the Ethics committee of X hospital under the protocol number XXXX.” If your study does not require ethical approval, please state that : “Ethical approv…
原文 ↗出版商官网 ·- 开放获取 1.8 Open access
Open access journal 模型摘要
All articles published in Visualized Cancer Medicine are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Articles are available from the website of the journal (https://vcm.edpsciences.org/), from PubMed Central as soon as the indexation of the journal is effective and from Europe PubMed Central, in various formats.…
原文 ↗出版商官网 ·- 同行评审
作者被邀请遵循ICMJE制定的'医学期刊学术工作实施、报告、编辑与出版建议',相关内容见ICMJE网站。 模型中文摘要
Authors are invited to comply with the “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals”, which were established and made available by the International Committee of Medical Journal Editors (ICMJE) at: http://www.icmje.org/recommendations/.
原文 ↗出版商官网 ·- 查重
抄袭是稿件被立即拒稿的常见原因;使用Similarity Check工具检测文本可发现哪怕最轻微的抄袭,因此作者被邀请阅读伦理标准并按其指示执行,以避免这一处罚。 模型中文摘要
A frequent reason of immediate rejection is plagiarism. Using the Similarity Check tool for the text, allows to detect even minimal plagiarism. Thus authors are invited to read the ethical standards and apply the given indications in order to avoid this sanction.
原文 ↗出版商官网 ·- 试验注册 / 报告规范 1.5 Reporting guidelines and clinical trial registration
根据研究设计应遵循CONSORT、STROBE、PRISMA、STARD等报告指南,更多信息可访问EQUATOR网络或NLM网站;ICMJE的临床试验注册政策载于其建议中,本期刊作者应予遵循。 模型中文摘要
Depending on the study design, reporting guidelines such as CONSORT, STROBE, PRISMA, STARD should be followed. For more information about these guidelines authors should visit the websites of the EQUATOR network or the corresponding sources at the NLM website. The policy for clinical trial registration by the ICMJE is given in their recommendations. These should be followed by the authors in this …
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- EDP Sciences
- 出版国家或地区
- France
- 出版语言
- English
- ISSN
- 2740-4218
- 学会 / 主办单位
- Society of Tumor Microenvironment
- 官方链接
- 期刊主页 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 费用减免政策 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
- 查重政策 ↗DOAJ
常见问题
关于 Visualized Cancer Medicine 的常见问题
Visualized Cancer Medicine 的审稿周期多长?
投稿社区反馈的平均审稿速度为约 8 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
Visualized Cancer Medicine 的投稿格式要求是什么?
据期刊作者指南:摘要:≤ 400 词;关键词:4–6 个;参考文献格式:Vancouver 格式。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Visualized Cancer Medicine 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Visualized Cancer Medicine 被 DOAJ 收录。
Visualized Cancer Medicine 是开放获取期刊吗?版面费多少?
Visualized Cancer Medicine 为钻石开放获取(无 APC)。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。